i m on tirzepatide and not losing weight Why Am Tirzepatide? Your Questions Answered Why am I not losing

Eli Lillys Orforglipron Hits Target in Diabetes TrialOral GLP-1 Battle with Novo Nordisk Heats Up Key Takeaways 10.5% average weight loss in overweight/obese patients with Type 2 diabetes over ~72 weeks on orforglipron

doi: 10.1016/j.scitotenv.2021.149271

Patient education should focus on recognising symptoms of drug interactions and understanding the importance of medication adherence

People with severe obesity will be able to access the drugs via Medicare at a $50 co-pay, starting as soon as mid-2026

Glutathione helps keep it strong

While GLP-1RAs have been linked to a statistically significant elevation in the risk of early-stage DR events compared to placebo, they may conversely demonstrate a protective effect against the progression to advanced-stage diabetic retinopathy when compared to insulin therapy [81]